PUBLISHER: The Business Research Company | PRODUCT CODE: 1713593
PUBLISHER: The Business Research Company | PRODUCT CODE: 1713593
An implantable insulin pump is a surgically implanted device designed to deliver insulin directly into the peritoneal cavity, continuously adjusting doses based on the patient's needs. This device helps individuals with diabetes maintain stable blood sugar levels, reducing the risk of long-term complications and providing a more effective alternative to daily insulin injections.
The main types of implantable insulin pumps are closed-loop insulin pumps and open-loop insulin pumps. Closed-loop insulin pumps, also known as artificial pancreas systems, are advanced devices that automatically regulate blood sugar levels. They are used for managing both type 1 and type 2 diabetes and are utilized in various settings, including hospitals and home care environments.
The implantable insulin pumps market research report is one of a series of new reports from The Business Research Company that provides implantable insulin pumps market statistics, including implantable insulin pumps industry global market size, regional shares, competitors with a implantable insulin pumps market share, detailed implantable insulin pumps market segments, market trends, and opportunities, and any further data you may need to thrive in the implantable insulin pumps industry. This implantable insulin pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The implantable insulin pump market size has grown strongly in recent years. It will grow from $3.54 billion in 2024 to $3.88 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to the increasing prevalence of diabetes, improvements in insulin delivery systems, growing awareness of diabetes management, rising patient demand for convenience, and supportive government regulations for diabetes care.
The implantable insulin pump market size is expected to see strong growth in the next few years. It will grow to $5.57 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to expanding patient population with diabetes, rising adoption of personalized medicine, increasing focus on diabetes management efficiency, growing demand for non-invasive monitoring solutions, and expanding healthcare infrastructure and accessibility. Major trends in the forecast period include the integration of AI and machine learning for better insulin management, enhancements in device miniaturization, integration with mobile apps and cloud-based systems, the development of pumps with enhanced safety mechanisms, and ongoing research and innovations.
The growing prevalence of diabetes is anticipated to drive the expansion of the implantable insulin pump market. Diabetes is a chronic condition characterized by the body's difficulty in managing blood sugar levels due to insufficient insulin production or ineffective use of insulin by cells. The increase in diabetes cases is attributed to factors such as rising obesity rates, sedentary lifestyles, poor diets, and an aging population. Implantable insulin pumps provide precise, continuous insulin delivery, which helps stabilize blood glucose levels, reduces the need for frequent injections, and enhances overall diabetes management and quality of life. For example, a report from Diabetes UK in May 2024 highlighted that there were over 5.6 million people with diabetes in the UK, reflecting an increase of 167,822 cases from the previous year. Consequently, the surge in diabetes incidence is propelling the growth of the implantable insulin pump market.
Key players in the implantable insulin pump market are focusing on developing advanced products, such as closed-loop insulin pump systems, to enhance patient outcomes through automated insulin delivery based on real-time glucose data. Known as an artificial pancreas, a closed-loop insulin pump system uses real-time glucose information to adjust insulin infusion without manual intervention. For instance, Medtronic India Pvt. Ltd., an India-based medical device company, introduced the MiniMed 780G system in March 2022. This next-generation closed-loop insulin pump system delivers basal insulin and correction boluses every five minutes to help stabilize blood sugar levels. It features customizable glucose targets as low as 100 mg/dL, offering superior glucose control compared to other advanced hybrid systems. The system's Bluetooth connectivity allows users and their care partners to monitor real-time glucose data and trends through compatible iOS and Android apps, simplifying management with minimal adjustments required for optimal performance.
In June 2024, Arecor Therapeutics plc, a UK-based biotechnology firm, partnered with Medtronic plc to develop a high-concentration, thermostable insulin for use in Medtronic's advanced implantable insulin pumps. This collaboration aims to improve treatment for diabetes patients who require intensive insulin management. Medtronic plc, based in Ireland, is a manufacturer of implantable insulin pumps.
Major companies operating in the implantable insulin pump market are Sanofi S.A., Abbott Laboratories, Medtronic plc, Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Air Liquide Healthcare Ltd., Diabeloop SA, Glooko Inc., ViCentra B.V., Bigfoot Biomedical Inc., Beta Bionics Inc., Senseonics Holdings Inc., INREDA DIABETIC B.V., TIDEPOOL Inc., Medtrum Technologies Inc., Sernova Corp., PhysioLogic Devices Inc., EOFLOW CO. LTD., CamDiab Ltd.
North America was the largest region in the implantable insulin pump market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable insulin pump market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the implantable insulin pump market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The implantable insulin pump market consists of sales of pump devices, delivery catheters, control systems, and insulin reservoirs. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Implantable Insulin Pump Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on implantable insulin pump market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for implantable insulin pump ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable insulin pump market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.